Inferences

Our team is known for policy analysis, particularly evidence-based analysis, which we publish as inferences

Inference

Medicare Part D LIS Overview

Medicare Part D paid for outpatient prescription drug coverage on behalf of 49 million Medicare beneficiaries in 2021.  ...

Inference

Medicare Part D LIS Overview

Medicare Part D paid for outpatient prescription drug coverage on behalf of 49 million Medicare beneficiaries in 2021.  ...

Inference

Medicare Analytics: Case Study of Part D Coverage Gap Utilization for an Oral Oncology Brand

In this analysis, Qualia Bio analyzed the 2019 Medicare Part D Files (including PDPs and MA-PDs) to assess select Part D...

Inference

Utilization Management Policy Criteria: A Migraine Model Policy Case Study

To help communicate a migraine manufacturer’s UM policy goals with payers, Qualia Bio developed a model policy for Produ...

Inference

Issue Brief: Medicare Reimbursement for New Oncology Therapies and Geographic Access to Care

Qualia Bio analysis estimates that diffuse large B-cell lymphoma (DLBCL) patients may be enduring unnecessarily high tra...

Inference

US Market Access Report: Utilization Management Analysis of the R/R DLBCL Market for CAR-T's

As a relatively new and unique therapeutic area, CAR-T’s represent a high level of uncertainty to payers given the high ...

Inference

Medicare Cost Report

What Are Medicare Cost Reports?….Medicare Cost Reports are also used by providers, financial analysts, and researchers t...

Inference

FY 2021 IPPS Proposed Rules & CAR T Therapies

CMS released the FY 2021 Inpatient Prospective Payment System Proposed Rules

Inference

Cost-to-Charge Ratios: Trends Report

Hospitals Mark Up Services and Treatments to Billed to Medicare

Inference

A Snapshot of the Conclusions on Long-term Value of Healthcare Treatments Conducted by the Institute for Clinical and Economic

Institute for Clinical and Economic Review has published multiple assessments of healthcare technologies which provide a...

Search

Showing 9 of 9